WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, June 1, 2003, 23(11):4785-4790

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (55)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deroche-Gamonet, V.
Right arrow Articles by Piazza, P. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deroche-Gamonet, V.
Right arrow Articles by Piazza, P. V.

 Previous Article  |  Next Article 

The Glucocorticoid Receptor as a Potential Target to Reduce Cocaine Abuse

Véronique Deroche-Gamonet,1 * Inge Sillaber,2 * Bruno Aouizerate,1 Ryozuke Izawa,1 Mohamed Jaber,1 Sandy Ghozland,1 Christoph Kellendonk,3 Michel Le Moal,1 Rainer Spanagel,4 Günther Schütz,3 François Tronche,3,5 and Pier Vincenzo Piazza1

1 Institut National de la Santé et de la Recherche Médicale, Unité 588, Bordeaux 33077, France, 2 Max Planck Institute of Psychiatry, D-80804 Munich, Germany, 3 Molecular Biology of the Cell I, Deutsches Krebsforschungzentrum, 69120 Heidelberg, Germany, 4 Department of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, 68159 Mannheim, Germany, and 5 Centre National de la Recherche Scientifique, FRE2401, Institut de Biologie, Collège de France, Paris 75231 Cedex 5, France

Several findings suggest that glucocorticoid hormones are involved in determining the propensity of an individual to develop cocaine abuse. These hormones activate two related transcription factors, the glucocorticoid receptor (GR) and the mineralocorticoid receptor. In this study, we show that the selective inactivation of the GR gene in the brains of mice profoundly flattened the dose–response function for cocaine intravenous self-administration and suppressed sensitization, two experimental procedures considered relevant models of addiction. Furthermore, administration of a GR antagonist dose-dependently reduced the motivation to self-administer cocaine. Importantly, the absence of GR did not modify the basal behavioral and molecular effects of cocaine but selectively modified the excessive response to the drug spontaneously present in certain vulnerable individuals or induced by repeated drug exposure in others. In conclusion, we provide the first genetic evidence that the GR gene can modulate cocaine abuse. This suggests that targeting GR function in the brain could provide new therapeutic strategies to treat cocaine addiction for which there is no available treatment.

Key words: cocaine; self-administration; intravenous; sensitization; glucocorticoid receptor; mifepristone; transgenic; c-Fos


Received Dec. 9, 2002; revised Mar. 21, 2003; accepted Mar. 21, 2003.




This article has been cited by other articles:


Home page
EndocrinologyHome page
E. M. Richard, J.-C. Helbling, C. Tridon, A. Desmedt, A. M. Minni, M. Cador, L. Pourtau, J.-P. Konsman, P. Mormede, and M.-P. Moisan
Plasma Transcortin Influences Endocrine and Behavioral Stress Responses in Mice
Endocrinology, February 1, 2010; 151(2): 649 - 659.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Nunez, A. Foldes, D. Perez-Flores, J. C. Garcia-Borron, M. L. Laorden, K. J. Kovacs, and M. V. Milanes
Elevated Glucocorticoid Levels Are Responsible for Induction of Tyrosine Hydroxylase mRNA Expression, Phosphorylation, and Enzyme Activity in the Nucleus of the Solitary Tract during Morphine Withdrawal
Endocrinology, July 1, 2009; 150(7): 3118 - 3127.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
E. J Nestler
Transcriptional mechanisms of addiction: role of {Delta}FosB
Phil Trans R Soc B, October 12, 2008; 363(1507): 3245 - 3255.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Duret, M. Daujat-Chavanieu, J.-M. Pascussi, L. Pichard-Garcia, P. Balaguer, J.-M. Fabre, M.-J. Vilarem, P. Maurel, and S. Gerbal-Chaloin
Ketoconazole and Miconazole Are Antagonists of the Human Glucocorticoid Receptor: Consequences on the Expression and Function of the Constitutive Androstane Receptor and the Pregnane X Receptor
Mol. Pharmacol., July 1, 2006; 70(1): 329 - 339.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Yang, X. Zheng, Y. Wang, J. Cao, Z. Dong, J. Cai, N. Sui, and L. Xu
Stress Enables Synaptic Depression in CA1 Synapses by Acute and Chronic Morphine: Possible Mechanisms for Corticosterone on Opiate Addiction
J. Neurosci., March 10, 2004; 24(10): 2412 - 2420.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Bezard, S. Dovero, D. Belin, S. Duconger, V. Jackson-Lewis, S. Przedborski, P. V. Piazza, C. E. Gross, and M. Jaber
Enriched Environment Confers Resistance to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine and Cocaine: Involvement of Dopamine Transporter and Trophic Factors
J. Neurosci., December 3, 2003; 23(35): 10999 - 11007.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2010 by Society for Neuroscience ONLINE ISSN: 1529-2401
-